HARRISBURG, PA — Democrat Governor Tom Wolf has signed legislation into law to facilitate state-sponsored medical cannabis research. The amended law, House Bill 2477, states: “It is the intention of the General Assembly to create a mechanism whereby this Commonwealth’s medical schools and hospitals may provide advice to grower/processors and dispensaries in the areas of patient health and safety, […]
MADISON, WI — Members of the Wisconsin Assembly and Senate have unanimously approved legislation, Senate Bill 119, to establish a state-sponsored pilot program to “study the growth, cultivation, and marketing of industrial hemp.” The measure now awaits final approval from Republican Gov. Scott Walker. Under a 2014 federal law, states may license hemp cultivation as part of a university sponsored […]
The American Legion has been calling on the federal government for over a year – specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD. Many veterans have said that they have been able to eliminate or reduce their dependency on other drugs, specifically opioids, […]
SANTA FE, NM — New Mexico Governor Susana Martinez has vetoed a pair of measures that sought to establish a hemp research program through the state’s Department of Agriculture. The Governor gave no public explanation for the vetoes. The Governor has historically been an outspoken opponent of marijuana law reform efforts – receiving an ‘F’ […]
Kentucky gears up for third year of hemp research projects
The Kentucky Department of Agriculture started these industrial hemp research projects to study production, processing and potential products. "It's important to note that Kentucky, back in 2014 reintroduced a crop that had not been seen for decades," …
Read more on WBKO
Nike Brings Back Hemp Sneaker for 4/20
Currently, millions of dollars worth of hemp are imported every year for American industries. Companies like Nike use hemp fibers in sneakers; our automobile industry uses hemp fibers to produce plastic and car door panelling. In 2014, we spent an …
Read more on Ora TV
Ottawa, ON (PRWEB) February 12, 2015
Vida Cannabis Corp. today announced the official launch of its new website vidacannabis.com. Vida’s site serves as an information resource for the growing number of Canadians who are utilizing legal medical cannabis to treat a multitude of ailments.
The site includes a Learning Centre that addresses questions for patients and doctors about the types of conditions that can be treated with cannabis, how cannabis works, who cannabis helps, and the future of cannabis based medicine.
“We want doctors, patients and stakeholders to learn about all aspects of medical cannabis through powerful videos, concise explanations and our downloadable e-booklet,” said Greg Wilson, Vida Cannabis CEO. “Our goal is to engage, educate, inform and then facilitate access for Canadians to receive the best quality medicine. We believe our new website demonstrates the experience, expertise, professionalism and dedication of the entire Vida team.”
The site features HD videos showcasing Vida’s 315,000-square-foot production facility in Stellarton, Nova Scotia, and its industry leading level-10 security protocols that are directed by former RCMP Chief Superintendent Derek Ogden, Vida’s Chief Operating Officer.
Vida’s emphasis on science and research also come into focus on the new site. Dr. Pritesh Kumar, Vida’s Chief Cannabinoid Research Scientist & Quality Assurance Manager, leads the research team. His entire career is focused on understanding the bioactive components of the cannabis plant. Honoured for his research publications and respected for his innovative research design, Dr. Kumar is at the forefront of the quest to bring 21st century cellular level understanding to the medicinal properties of cannabinoids.
On the cultivation side, Vida has brought together five of the most talented growers from Canada’s west-coast. Known as “The Vida 5” the team is led by Head Master Cultivator Stephen Schroeder.
“Vida shares our standards of integrity and compassion. Our new hydroponic facility is a grower’s dream come true,” says Schroeder.
About Vida Cannabis:
Vida Cannabis Corp. is working to develop uniquely high quality solutions to meet customer needs in the growing global marketplace for legal cannabis-based products. Initial operations are centered in the Canadian market, where the Federal Government has established national guidelines enabling best-in-class producers to acquire commercial production licenses for medicinal purposes. Vida has assembled one of the top management teams in the world, and has extensive access to expertise and resources in the United States, Canada and Europe. Its 315,000-square-foot production facility, located in Stellarton, Nova Scotia, will be one of the largest, most advanced medical marijuana facilities in Canada.
This announcement does not constitute or form part of, and shall under no circumstances be considered as, an offer to sell, a solicitation to purchase, or advice on investments in any securities of Vida Cannabis Corp. (“Vida Cannabis”). Offers and solicitations shall be expressly identified as such and made in compliance with applicable securities laws. This announcement is for information purposes only. It should not be relied upon as a basis for investment decisions. You should consult with your own investment, accounting, legal and tax advisers to evaluate independently the risks, consequences and suitability of any investments you are considering. Whilst the information provided here is believed to be reliable, it cannot be guaranteed. It may contain forward-looking statements made by or on behalf of Vida Cannabis about its business or financial objectives, position, strategies or expectations. Such forward-looking statements may be identified by words such as, or similar to, “intends,” “anticipates,” “believes,” “expects” and “hopes” and includes, without limitation, the development of production facilities, approval from regulatory authorities and the ability for Vida Cannabis to obtain adequate financing to meet its business objectives. These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated. The statements in this announcement do not guarantee future performance. Vida Cannabis does not undertake any obligation to update any information provided in this announcement. In Canada, Vida Cannabis (Canada) Ltd., a wholly owned subsidiary of Vida Cannabis, must obtain approval from Health Canada in order to operate as a licensed commercial producer under the Marihuana for Medical Purposes Regulations. Vida Cannabis makes no representations or warranties that it will receive Health Canada approval.
New York, NY (PRWEB) April 09, 2015
The Medical and Recreational Marijuana Growing industry has flourished over the five years to 2015. For decades, all marijuana transactions in the United States were conducted under implicit or explicit prohibition. However, states have increasingly moved to legalize nonprofit marijuana for medical purposes, as well as to implement regulations for organizations that sell cannabis. “The growing acceptance of medical marijuana is providing growers and investors with unprecedented opportunities,” says IBISWorld Industry Analyst Dmitry Diment. “There has been no shortage of demand in recent years, as the industry has benefited from increased acceptance of the legitimacy of medical marijuana products.”
Recently, the legalization of recreational marijuana in Colorado and Washington has spurred additional demand for the industry. In 2014, the licensing of commercial recreational marijuana growers in these states contributed to industry revenue growth of 54.7%. In addition to the favorable regulatory environment in these states, medical marijuana growers have continued to benefit from the steadily aging population. Chronic illnesses have become more prevalent as the population continues to age, driving demand for medical marijuana. Overall, the industry is expected to experience annualized revenue growth of 30.2% to $ 1.9 billion in the five years to 2015, including growth of 25.1% during the current year.
According to Diment, however, “The industry will remain at risk until the federal government definitively changes its position on the legality of marijuana. Until then, a growing number of medical marijuana patients, as well as a burgeoning recreational cannabis legalization movement, will spur demand for the industry.” Rising demand is also forecast to widen profit margins, as is the success of the for-profit recreational marijuana business in Colorado and Washington. In particular, the next five years are expected to see the growth of large commercial cultivators, who will benefit from strong recreational demand across a number of states, including Alaska, Oregon and the District of Columbia.
For more information, visit IBISWorld’s Medical and Recreational Marijuana Growing in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry’s establishments grow marijuana for medical and recreational use. Most operators are nonprofit collectives that provide medical marijuana to other collective members. Transactions are typically conducted on a donation basis because the sale and distribution of marijuana is illegal in most states that permit medical marijuana. The industry also includes operators in Colorado and Washington, who grow medical and recreational marijuana on a for-profit basis.
Key External Drivers
Industry Life Cycle
Products & Markets
Products & Services
Globalization & Trade
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Bradley University’s Dr. Luke Haverhals, Assistant Professor of Chemistry, discusses his research on natural fibers and how hemp can be used for fiberglass in cars, building materials and many other sustainable products. #Hemp
Source: Chicago Tribune, Abel Uribe
Footage: Campaign for the Restoration and Regulation of Hemp (CRRH) http://hemp.org
Video Rating: 5 / 5
Watch in HD!!
this is basically my review on this product please enjoy! 🙂
Disclaimer: this is my honest opinion on this product, i purchased this product with my own money i am not being paid to review this product
Virginia Tech to research production, use, and economic impact of industrial hemp
vtech-logo Virginia Tech will be able to begin research on growing industrial hemp in the commonwealth as a result of a new state law and the establishment of an industrial hemp research program by the Virginia Department of Agriculture and Consumer …
Read more on Augusta Free Press
Bill to Legalize Hemp Farming, Nullify Federal Ban, Passes Washington House …
…allows State Agriculture Departments, colleges and universities to grow hemp, defined as the non-drug oilseed and fiber varieties of Cannabis, for academic or agricultural research purposes, but it applies only to states where industrial hemp farming …
Read more on Tenth Amendment Center (blog)
New York, NY (PRWEB) November 05, 2014
The legalization of recreational marijuana in Alaska, Oregon and the District of Columbia will propel the cannabis sector in several key ways, from increasing the flow of capital into legal marijuana companies to setting up a 2016 legalization push in California, Viridian Capital & Research believes.
Even the losing vote for medical marijuana in Florida supports the secular growth of this market, Viridian believes, since the measure nearly passed despite mistakes by its backers, who unnecessarily associated the measure with partisan Democratic politics during a Republican landslide election.
Oregon and Alaska now join Colorado and Washington State, which legalized recreational marijuana in 2012. State officials in Oregon and Alaska will move to create the administrative system for marijuana sales, which are expected to begin in both states by 2016. Voters in the District of Columbia passed what has been called “soft legalization,” which allows citizens to possess and grow small amounts of marijuana, but does not create cannabis stores (the DC initiative must also be approved by Congress, where opposition is already brewing.)
The successful legislation in Oregon, Alaska, and the District of Columbia, along with the close result in Florida, will make 2015 a critical year for the cannabis industry. These midterm results will offer law makers in other states the confidence to introduce new initiatives for action in 2015 and placement on 2016 ballots. This trend will be accelerated if the sale of recreational marijuana in Colorado and Washington State appears to be a success, which appears likely.
Viridian expects the following actions resulting from yesterday’s elections:
More Bills to Legalize Recreation Cannabis: Viridian believes several states will see bills in 2015 to legalize recreational marijuana and that legalization could be on the ballot in 7-13 states –most notably California — during the 2016 elections.
Emergence of Marijuana as a 2016 Presidential Election Issue: Viridian’s sources suggest that both Republican and Democratic parties may adopt pro legal-cannabis positions and talking points during the 2016 Presidential elections.
Marijuana Tax Battles, Starting with Oregon and Washington State: Oregon’s imposed tax of $ 35 per ounces, is less than Colorado and more importantly less its neighbor to the north, Washington State. Due to high taxes in Washington, consumers can expect an ounce of cannabis in Seattle to cost over $ 500. Compared to it costing consumers anywhere from $ 145 – $ 200 an ounce when Oregon goes live. As a result, Viridian believes that this could negatively impact the Washington market, since many consumers will just travel across the border to purchase recreational cannabis at a much lower cost.
Continued Increase in Cannabis Sales, Profits and Tax Revenues: The continued efforts of states beginning to roll out their respective legal cannabis markets will result in additional states having recreational cannabis markets online, an increased number of total licenses in the US being granted to qualified entrepreneurs, and numerous dispensaries opening up in these markets. Viridian believes these factors support its estimate of the cannabis industry growing to over $ 10 billion dollars by 2018.
Growth of the Capital Markets for Cannabis Companies: Viridian expects continued growth in the number of cannabis companies looking to access the capital markets to raise growth capital and/or execute M&A strategies. As valuations in the public cannabis companies continue to rationalize, we may see increasing interest on the part of investment funds to take equity stakes in cannabis enterprises, versus the straight debt and convertible debt financing that has made up the bulk of financing in public cannabis companies to date.
Movement in Public Cannabis Market Stock Index: Viridian expects continued volatility in the public markets for the cannabis industry, which have seen lofty valuations, rampant speculation, and increased regulatory oversight. The “whipsaw” nature of these companies’ stock price and volume has created a “Wild West” environment that attracts retail traders, momentum investors and shorts. Volatility was especially pronounced leading up to the 2012 elections, when Colorado and Washington voted to legalize recreational marijuana, as well as the months following. This continued around the launch of Colorado’s recreational cannabis market in January 2014. Following these events, the cannabis sector experienced significant contractions after momentum from the hype and promotion died down and valuations began to rationalize. For more on the cannabis stocks sector see the charts below and the Viridian Cannabis Stock Index report at: http://viridiancr.com/industry-report
Snapshots of Measures Voted on Yesterday:
Oregon passed the “Control, Regulation, and Taxation of Marijuana and Industrial Hemp Act,” which will implement a system similar to that in Washington State, but with lower taxes. The measure allows residents 21 and older to possess up to eight ounces of marijuana — a considerable increase from the single ounce permitted by Colorado and Washington. It grants the Oregon Liquor Control Commission primary oversight and regulatory authority over the sector, with input from the state’s Department of Agriculture and the Oregon Health Authority. Four types of cannabis businesses will be permitted: Cannabis producers, who cultivate marijuana for wholesale; cannabis processors, who produce cannabis extracts and products; cannabis wholesalers, who purchase cannabis and cannabis products to sell to retailers and other non-consumers; and cannabis retailers, who sell cannabis and cannabis products to individuals 21 and older. One of the most important features of the act is its level of state tax on marijuana, assessed by weight. Oregon’s tax of $ 35 per ounces is less than Colorado and more importantly, far lower than its neighbor to the north, Washington State. Due to high taxes in Washington, consumers can expect an ounce of cannabis in Seattle to cost over $ 500. In contrast, in Oregon recreational cannabis will cost anywhere from $ 145 – $ 200 an ounce. Many believe this will hit Washington cannabis companies hard, as users need only jump across the border to get a dramatic discount on their marijuana.
Alaska’s successful Ballot Measure 2 has many similarities to Oregon’s Measure 91. An important difference is that Alaska’s law allows the state legislature to create a new Marijuana Control Board – failing that, Alaska’s Alcohol Beverage Control Board will be tasked with creating regulations and licensing requirements. There will be much work to do, since the state has limited administrative frameworks around its medical marijuana system. For example, the Alaska lacks a regulated wholesale system, but rather relies on “home grows” and caregivers for production and supply of cannabis to the medical market. As a result, Alaska will need to work with experts from other recreational and medical cannabis states to design and implement regulations for the recreational market.
Voters in the District of Columbia passed Initiative 71 Tuesday night. Earlier this year D.C. implemented a marijuana decriminalization bill, which removed all criminal penalties for possession of up to an ounce of cannabis and replaced them with a civil fine of $ 25. Initiative 71 takes decriminalization a step further, allowing adults 21 years and older to possess up to two ounces of marijuana and cultivate up to six plants (with no more than three being mature) in their private residences. Adults could give away up to an ounce of marijuana, but sales would still be criminal. The initiative also removes penalties for use and sale of marijuana paraphernalia. However, Congress has to approve the new law. That risk, plus the lack of a commercial framework in the current measure and the District’s existing medical marijuana system, indicate recreational marijuana sales are not likely to reach DC in the near future.
Florida’s medical marijuana amendment earned a majority of the votes but failed to reach the 60% needed to pass. Many observers attribute the failure to errors by the measure’s key backers, which gave the measure a democratic partisan hue on a Republican day, plus the generally older and more conservative makeup of the midterm electorate.
Supporters pledge to take the fight to the 2015 Florida legislative session and, if that fails, have it back on the ballot in 2016. Given how close the measure came to passing this year, it appears likely medical marijuana is in the future of Floridians.
Viridian Capital & Research
Viridian Capital & Research (VCR) http://www.viridiancr.com @ViridianCap was formed by experienced investment bankers to bring capital markets expertise, institutional research coverage and strategic direction to the emerging Cannabis Sector. VCR is a boutique banking and strategic advisory firm that helps clients improve the value of their enterprises by providing research, investment banking, investor relations and corporate development services. Our banking practice, through affiliate Pickwick Capital Partners, provides capital and M&A services to fund the growth of our clients, while our advisory practice helps position and build their cannabis businesses. VCR research and market intelligence are recognized for their unique value and cited by leading market observers, including Institutional Investor.
Broker dealer services provided through Pickwick Capital Partners, LLC Member FINRA SIPC.
Related Hemp Legislation Press Releases